Mel Formica

Member of the Board at Pamanicor Health AG
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Zurich Area, CH

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Switzerland
    • Business Consulting and Services
    • 1 - 100 Employee
    • Member of the Board
      • 2018 - Present

      Pamanicor Health AG is one of the first global boutique advisory firms combining the promise of transformative technologies such as AI, Blockchain & Data with Life Science & Biotech innovation. With interdisciplinary and pragmatic solutions for sustainable healthcare, we bridge all aspects of Digital & Health, Life Science & Biotech, Policy & Regulation, PE & VC. Identifying disruptive trends and shaping a highly interconnected, regulated, and global digital eco-system. Trusted advisors to C-Suites, leading multinationals to start-ups, governments, investors, academia and nonprofit organizations worldwide focused at the forefront of digital transformation. Accomplished executives with extensive experience in US, Europe, Australia and Asia. Show less

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • President, Value, Access & Data Sciences
      • 2022 - 2023

      Envision Pharma Group, a GHO Capital Partners portfolio company, is a global provider of evidence-based communication services and industry-leading technology solutions serving pharmaceutical, biotechnology, and medical device companies. Initially focusing on reinventing the way biopharma companies managed their global data communications programs through the use of smart technology and best-in-class publication planning, Envision has evolved to become a leading provider of healthcare communications services and medical affairs technology solutions supporting clients throughout the pharmaceutical product lifecycle. Show less

    • United States
    • Research Services
    • 400 - 500 Employee
    • Global Head, Value and Development Consulting
      • 2018 - 2022

      Evidera is a business unit within Pharmaceutical Product Development, LLC, (PPD) a global contract research organization (CRO), and a provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. Evidera is a business unit within Pharmaceutical Product Development, LLC, (PPD) a global contract research organization (CRO), and a provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity.

    • Japan
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Vice President, Global Market Access
      • 2013 - 2017

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Head, Value & Access – Europe, Zug Switzerland
      • 2010 - 2012

    • Executive Director, Global Pricing and Payer Planning
      • 2006 - 2010

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Principal
      • 2004 - 2006

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Marketing
      • 2000 - 2004

    • United States
    • Higher Education
    • 200 - 300 Employee
    • Assistant Research Scientist (Assistant Professor), Department of Medicine
      • 1998 - 1999

    • Post-Doctoral Research Scientist, Department of Medicine
      • 1995 - 1998

    • Australia
    • Higher Education
    • 700 & Above Employee
    • Research Officer – Department of Medicine
      • 1989 - 1995

    • Research Assistant – Department of Medicine
      • 1988 - 1989

Education

  • University of Melbourne
    Ph.D., Medicine
    1992 - 1995
  • Pace University - Lubin School of Business
    Executive MBA
    2000 - 2002

Community

You need to have a working account to view this content. Click here to join now